Sebastian Halbach

1.3k total citations
16 papers, 453 citations indexed

About

Sebastian Halbach is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Sebastian Halbach has authored 16 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Hematology. Recurrent topics in Sebastian Halbach's work include Melanoma and MAPK Pathways (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Sebastian Halbach is often cited by papers focused on Melanoma and MAPK Pathways (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Sebastian Halbach collaborates with scholars based in Germany, Australia and Switzerland. Sebastian Halbach's co-authors include Tilman Brummer, Ricarda Herr, Sandra Braun, Thalia Erbes, Bernd Kammerer, Elmar Stickeler, Melanie Boerries, Michael Röring, Wolfgang W. Schamel and Katharina Heilmann and has published in prestigious journals such as The EMBO Journal, Cancer Research and Oncogene.

In The Last Decade

Sebastian Halbach

15 papers receiving 448 citations

Peers

Sebastian Halbach
Martine B.W. Prinsen Netherlands
Joe Lyssikatos United States
Wayne Blosser United States
Michael Grondine United States
Gretchen A. Repasky United States
Akito Nakamura Japan
Candice L. Horn United States
Alyson K. Freeman United States
Zoi Karoulia United States
Hélène Malka-Mahieu France
Martine B.W. Prinsen Netherlands
Sebastian Halbach
Citations per year, relative to Sebastian Halbach Sebastian Halbach (= 1×) peers Martine B.W. Prinsen

Countries citing papers authored by Sebastian Halbach

Since Specialization
Citations

This map shows the geographic impact of Sebastian Halbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sebastian Halbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sebastian Halbach more than expected).

Fields of papers citing papers by Sebastian Halbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sebastian Halbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sebastian Halbach. The network helps show where Sebastian Halbach may publish in the future.

Co-authorship network of co-authors of Sebastian Halbach

This figure shows the co-authorship network connecting the top 25 collaborators of Sebastian Halbach. A scholar is included among the top collaborators of Sebastian Halbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sebastian Halbach. Sebastian Halbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Feuerstein, Reinhild, Lisa Marx, Ian J. Frew, et al.. (2026). Novel Syngeneic Cell Lines for Studying High-Risk BRAFV600E-Driven Colorectal Cancer In Vivo. Cancer Research Communications. 6(2). 320–339.
2.
Braun, Sandra, et al.. (2023). Analysis of RAS and drug induced homo- and heterodimerization of RAF and KSR1 proteins in living cells using split Nanoluc luciferase. Cell Communication and Signaling. 21(1). 136–136. 11 indexed citations
3.
Poggio, Teresa, Geoffroy Andrieux, Katharina Schönberger, et al.. (2021). Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo. Leukemia. 36(4). 970–982. 6 indexed citations
4.
Köhler, M., Sebastian Halbach, Ulrike Burk, et al.. (2019). B-Raf deficiency impairs tumor initiation and progression in a murine breast cancer model. Oncogene. 38(8). 1324–1339. 11 indexed citations
5.
6.
Reischmann, Nadine, Sanaz Taromi, Justin Mastroianni, et al.. (2017). The Atypical Kinase RIOK1 Promotes Tumor Growth and Invasive Behavior. EBioMedicine. 20. 79–97. 36 indexed citations
7.
Halbach, Sebastian, Zehan Hu, Christine Gretzmeier, et al.. (2016). Axitinib and sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells. Cell Communication and Signaling. 14(1). 6–6. 14 indexed citations
8.
Halbach, Sebastian, Jörn Dengjel, & Tilman Brummer. (2016). Quantitative Proteomics Analysis of Leukemia Cells. Methods in molecular biology. 1465. 139–148. 1 indexed citations
9.
Erbes, Thalia, Sebastian Halbach, Tilman Brummer, et al.. (2015). Exometabolom analysis of breast cancer cell lines: Metabolic signature. Scientific Reports. 5(1). 13374–13374. 26 indexed citations
10.
Schlimpert, Manuel, et al.. (2015). Metabolic profiling of breast cancer: Differences in central metabolism between subtypes of breast cancer cell lines. Journal of Chromatography B. 1000. 95–104. 53 indexed citations
11.
Bier, David, Maria Bartel, Katharina Sies, et al.. (2015). Small‐Molecule Stabilization of the 14‐3‐3/Gab2 Protein–Protein Interaction (PPI) Interface. ChemMedChem. 11(8). 911–918. 51 indexed citations
12.
Herr, Ricarda, M. Köhler, Hana Andrlová, et al.. (2014). B-Raf Inhibitors Induce Epithelial Differentiation in BRAF -Mutant Colorectal Cancer Cells. Cancer Research. 75(1). 216–229. 42 indexed citations
13.
Haug, Stefan, Dominik Schnerch, Sebastian Halbach, et al.. (2014). Metadherin exon 11 skipping variant enhances metastatic spread of ovarian cancer. International Journal of Cancer. 136(10). 2328–2340. 12 indexed citations
14.
Halbach, Sebastian, Kristoffer Rigbolt, Britta Diedrich, et al.. (2013). Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells. Cell Communication and Signaling. 11(1). 30–30. 10 indexed citations
15.
Halbach, Sebastian, Konrad Aumann, Sven Schwemmers, et al.. (2012). Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitors. Leukemia. 27(1). 118–129. 42 indexed citations
16.
Röring, Michael, Ricarda Herr, Gina J. Fiala, et al.. (2012). Distinct requirement for an intact dimer interface in wild‐type, V600E and kinase‐dead B‐Raf signalling. The EMBO Journal. 31(11). 2629–2647. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martine B.W. Prinsen Breakdown of academic impact, for papers by Joe Lyssikatos Breakdown of academic impact, for papers by Wayne Blosser Breakdown of academic impact, for papers by Michael Grondine Breakdown of academic impact, for papers by Gretchen A. Repasky Breakdown of academic impact, for papers by Akito Nakamura Breakdown of academic impact, for papers by Candice L. Horn Breakdown of academic impact, for papers by Alyson K. Freeman Breakdown of academic impact, for papers by Zoi Karoulia Breakdown of academic impact, for papers by Hélène Malka-Mahieu
Rankless by CCL
2026